“This Sent Chills Up My Spine” – Dave Hodges On Hagmann And Hagmann…(Must Listen!!!)

Thursday, September 18, 2014
By Paul Martin

By Susan Duclos
Allnewspipeline.com
September 18, 2014

The headline is a direct quote from Dave Hodges The Common Sense Show, and after listening to him connect the dots of what he calls “one of the greatest threats to public health,” on the Hagmann and Hagmann show below, the information, publicly available, should send chills down every single spine of those that listen to it.

Hodges imparts information that came to him from confidential sources, then as he states, he had an “AHA! moment,” and started digging, and what he uncovered, via information available to the general public online, shows despite knowing what we know about the Ebola outbreak, the spread, the CDC warnings that it is inevitable that it will appear in the US, if it hasn’t already, “It gets worse” Hodges explains, and then proceeds to lay out exactly how.

First Hodges shares what his DEA sources have told him, which is that border patrol agents are “scared to death,” of Ebola crossing the border via bioterrorism, then explains how he has received scanned copies of CDC emails sent to at least 11 states, on how to prepare for an Ebola outbreak in the US, making him assume that if 11 states received them, they must have been sent to all 50.

Then he started connecting dots by uncovering the connection between Ebola, the CDC which owns the Ebola patent, along with any related strain that has up to a 70 percent commonality, inlcuing hybrid strains, the NIH which owns the vaccine, a company called CRUCELL which has been working with Ebola and which is connected to Army research, NIH and Bill Gates who has invested up to $560 million into the Ebola vaccine.

Via The Common Sense Show website:

• Crucell is developing an Ebola vaccine in collaboration with the Vaccine Research Center (VRC) of the NIH National Institute of Allergy and Infectious Diseases (NIAID). It has been shown to completely protect monkeys against the virus with a single dose of the vaccine. • Under the terms of the agreement with VRC, Crucell has an option for exclusive worldwide commercialization rights to the Ebola vaccine. • Crucell’s Ebola vaccine entered Phase I clinical trials in Q3 2006. Two groups of 16 volunteers were enrolled and vaccinated. The study showed safety and immunogenicity at the doses evaluated. • In October 2008, Crucell secured a NIAID/NIH award to advance the development of Ebola and Marburg vaccines, with the ultimate aim of developing a multivalent filovirus vaccine. • The award provides funding of up to $30 million, with additional options, worth a further $40 million.

The Rest…HERE

Leave a Reply

Happy Holidays! Revolution Radio is a 100% volunteer run site. We appreciate any holiday cheer you can spare this Christmas season. God bless!

Follow us on Twitter